Loading clinical trials...
Loading clinical trials...
A Randomized, Global, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Once-daily Oral Avatrombopag for the Treatment of Adults With Thrombocytopenia Associated With Liver Disease Prior to an Elective Procedure
Conditions
Interventions
avatrombopag (lower baseline platelet count)
placebo (lower baseline platelet count)
+2 more
Locations
109
United States
Lancaster, California, United States
Long Beach, California, United States
Los Angeles, California, United States
Sacramento, California, United States
San Bernardino, California, United States
San Francisco, California, United States
Start Date
February 1, 2014
Primary Completion Date
January 26, 2017
Completion Date
February 27, 2017
Last Updated
February 27, 2018
Lead Sponsor
Eisai Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions